Slide 1: Rob Phillips CEO & Executive Chairman
Rob Phillips CEO & Executive Chairman
Slide 2: Agenda
AGENDA CHAIRMAN'S PRESENTATION Financial, Operational, Product and Uscom China 2019 RESULTS Global Growth 2020 STRATEGY More Products, More Markets and More Sales PROCEEDINGS Resolutions QUESTIONS Investors )) Uscom
Slide 3: The Uscom Board
THE USCOM BOARD Prof Rob Phillips EXECUTIVE CHAIRMAN é Mr Christian Bernecker NON-EXECUTIVE Mr Brett Crowley NON-EXECUTIVE
Slide 4: Uscom Team
USCOM TEAM P\. me Mh Rob Phillips Nick Schicht Teresa Guo Lucy Lu - Lebron Wei e8e2 Daniel Kenig Richard Scott —_Zsofia Kertesz ek le Szabolcs Hogye Szabo Gergo Catherine Gao Leo Luo Helen Zhang Curt Grosse ® ‘NS Rik Denicke George Ferenczi Kyana Chan Denise Pater ; George Tang Nancy Wang Andrea Mar
Slide 5: Introduction
\S8 “of aa INTRODUCTION “Uscom continues to build an international growth asset, and finished FY 2019 with record revenue, increased sales for all product suites, and expanded operations across four continents. Our improving fundamentals and investment in our global strategic expansion is BR planned
Slide 6: The Uscom Mission
THE USCOM MISSION WZ Uscom are the experts in circulation, delivering innovative, practice- changing, non-invasive cardiovascular and pulmonary monitoring devices to market. Our Vision To improve clinical care in cardiovascular and pulmonary medicine and to address the challenges of global disease.
Slide 7: Multiple products into multiple jurisdictions
Multiple products into multiple jurisdictions
Slide 8: Uscom Devices
REPORTER USCOM DEVICES stom = | J Advanced Haemodynamics APP . . SpiroSonic SMART Spiro, — WI } a SpirO3 ~ Uscom BP+
Slide 9: Uscom assists diagnosis and management of diseases responsible for ~75% of all global deaths
Uscom assists diagnosis and management of diseases responsible for ~75% of all global deaths
Slide 10: Our Business
OUR BUSINESS Increasing global complexity - Multiple products across 4 continents Distributors/sales Clinical/technical support * Concept * Regulatory (Man) * Regulatory (sales) ° IP * Assembly * Regional operations * Prototype * Quality * Management/registrations * Validation * Supply chain * Prici
Slide 11: 2019: Results Year Growth
2019: RESULTS 6 Year Growth Total income up 260% Sales up 358%
Slide 12: 2019: Results
2019: RESULTS KKK HK Hk Total expenses - $4.34m _Total Income - $3.64m (growing at 27% pa) _ Deficit - $0.7m pa Income, Expenses, and Loss 46 4s r 4 3.5 ae Income up 27% 3 3 02017 25 = 2018 9 3, te 20 ee Expenses up 3% ; Loss reduced 29% Income Expenses Loss after tax Uscom
Slide 13: 2019: Regional and Product Sales
2019: REGIONAL AND PRODUCT SALES SALES Regional Sales % 2019 Product Sales % 2019 China is the major Uscom market, and USCOM 1A the lead product. This will change as regulatory approvals are received for BP+ and SpiroSonic devices, particularly in China =China/Asia =Europe = USA etc. =USCOM 1A =Spir
Slide 14: Record Q4 Manufacture
_ PN RECORD O4 MANUFACTURE xD’, 4 Year on Year Growth % 160 Uscom BP+ 143 7 mUSCOM 1A mBP+ mSpiroSonic Year on year increase USCOM 17%, BP+ 143%, SpiroSonic 74%
Slide 15: Growing Global
GROWING GLOBAL Operations Sydney Beijing Budapest Offices S Singapore Sydne Auckland Ns ” auckland rendon } 7 A DEFENSIVE for CURRENCY and ECONOMICS =
Slide 16: Capital Initiatives
CAPITAL INITIATIVES $16M || 100% || $0.15 % Tightly Held ner 2017 90.847 90 Structure ~793 shareholders 60 ~142m shares on issue 3 shareholders hold ~40% 30 20 shareholders hold >67% 20 sgt ae to Z_omall parcels 3.227 Initiative 0.048 0.386 0.493 — = Small parcel consolidation <$500) 5,001-10,000 10
Slide 17: Capital Initiatives
CAPITAL INITIATIVES * Private placement for growth capital - 4 investors take 7% of UCM ($1.05m) * CEO/Chairman - Prof Rob Phillips (~20% of UCM) ° Director of China operations — Ms Teresa Guo ° Mr Meng - Beijing based international bio-investor (~20% of UCM) * Lead Australian Investor (~5%) ° Use o
Slide 18: 2019: ASX Announcements
2019: ASX ANNOUNCEMENTS 1 03/06/2019 2 13/05/2019 3 30/04/2019 4 25/03/2019 5 21/03/2019 6 28/02/2019 7 25/02/2019 8 07/02/2019 9 29/01/2019 10 14/01/2019 11 14/01/2019 12 28/11/2018 13 28/11/2018 Change in substantial holding Becoming a substantial holder Appendix 4C — quarterly ($) Uscom Granted T
Slide 19: Uscom China
USCOM CHINA “China remains the fastest growing medical device market worldwide” Business and finance registration arate Roe Import licences sues, auenneensnaoe NMPA for 7 [products progressed to final stages PWNs> Expanded dealer networks — increased sales = volume and margins 5. Type Il medical dev
Slide 20: AIR
AIR SpiroSonic AIR - NEW SOLUTION by SpiroSonic))) Chronic obstructive pulmonary disease in China: a nationwide prevalence study Liwen Fang", PeiGao", Heling Bao, Xun Tang, Baohua Wang, Yajing Feng, Shu Cong, Juan Juan, Jing Fan, Ke Lu, Ning Wang, Yonghua Hut, Linhong Wangt COPD - incidence 13.6% CO
Slide 21: SpiroSonic AIR - New Product by SpiroSonic
SpiroSonic AIR - NEW PRODUCT by SpiroSonic))) AIR by SpiroSonic ) BT4 digital ultrasonic spirometer MY, SpiroSonic ) Home care solution AIR spirometer and My AIR software Connected to cloud or SpiroReporter
Slide 22: Regulatory Pathways
REGULATORY PATHWAYS 30dys 15dys 100dys 2. Drafting of the Tech 4. Testing and Preparing Final 1. Documents, Collection, 3. Samples Requested and Sent to China 5. Submitted to 6. Admin NMPA for 7. Certificate Approval Issuance Requirements and Test Protocol Registration Documents Processing and Trans
Slide 23: 2019: Milestones
2019: MILESTONES ans . Uscom record sales and growth for all Uscom products . Uscom China expanded to support USCOM 1A, BP+ and SpiroSonic devices Wholly owned Beijing based subsidiary Regulatory applications for eight new China products approaching final stages Approval of sales license for all NMP
Slide 24: New Patents
NEW PATENTS Digital Multi-path Spirometry More accurate asthma and COPD monitoring jury Starts PATENT AND TRADEMARK OFTICE Cheeta, OH 4143108, BP+ Europe and US patents European 0) Patent Office Flow and Pressure Patent Real time, noninvasive stroke work, cardiac power, SMIl — “Holy Grail” USCOM 1A
Slide 25: Nobel Prize for Physiology and Medicine
Nobel Prize for Physiology and Medicine Greg Semenza, Peter Ratcliffe and William Kaelin Jr How cells sense and adapt to oxygen availability ° Every cell is an oxygen sensor feeding back to the brain to regulate the supply of oxygen, effecting the body in health and disease, particularly in cancer.
Slide 26: More Than Just a Company
MORE THAN JUST A COMPANY @) WHY USCOM MATTERS In 2010 | received an email from the Timisoara (Lithuania) Lions Club saying they wanted to buy an USCOM 1A for their local paediatric hospital for use in the ED and ICU Departments. After some discussion we got them their USCOM 1A, and installed and tra
Slide 27: Future: 2020 Strategy
FUTURE 2020: STRATEGY 1. Rapid operational growth — Deliver multiple products into multiple global markets Consolidate China market - grow marketing and sales collateral, clinical and technical support, expanded distribution partners - new distribution models/pricing Develop European and US markets
Slide 28: 2020: Risks
2020: RISKS . Unpredictable global markets — Trade wars, US recession and health contraction, Brexit, China slow down, Mid-East instability, North Korea etc. potentially create revenue and capital volatility Scale up stress — Rapid global growth may challenge cash flow management and capital adequac
Slide 29: Summary
SUMMARY =f NO oR WNM = . Established 6 year sales growth 29% pa CAGR (358%) . Investment - Two corporate acquisitions and global operations - Multiple products - USCOM 1A, BP+ and SpiroSonic (8 devices) - Multiple jurisdictions — China, Europe, US and Australia - Multiple currencies — USD, Eu, AUD,
Slide 30: Conclusion
CONCLUSION “Uscom has an established growth history and rapidly transforming fundamentals, while increasing products and international operations. This strategy is an investment in enduring accelerated global growth and value.” Rob Phillips CEO
Slide 31: Questions
. Questions \ ” GROWING _ GLOBAL SAI Rob Phillips CEO & Executive Chairman THANK YOU